Growth Metrics

Opus Genetics (IRD) EPS (Basic) (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Opus Genetics 357.99 Mn 298.03 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -257.14%
Dec 31, 2025 16.00%
Sep 30, 2025 -108.33%
Jun 30, 2025 50.00%
Mar 31, 2025 81.10%
Dec 31, 2024 -337.93%
Sep 30, 2024 3.33%
Jun 30, 2024 -3.45%
Mar 31, 2024 -38.10%
Dec 31, 2023 -180.77%
Sep 30, 2023 208.33%
Jun 30, 2023 14.29%
Mar 31, 2023 -116.28%
Dec 31, 2022 881.82%
Sep 30, 2022 12.00%
Jun 30, 2022 28.57%
Mar 31, 2022 -94.44%
Dec 31, 2021 28.00%
Sep 30, 2021 51.92%
Jun 30, 2021 85.43%
Mar 31, 2021 2.72%
Dec 31, 2020 -1,012.12%
Sep 30, 2020 23.26%
Jun 30, 2020 50.57%
Mar 31, 2020 -93.33%
Dec 31, 2019 8.16%
Sep 30, 2019 19.67%
Jun 30, 2019 1.61%
Mar 31, 2019 -588.89%
Dec 31, 2018 95.54%
Sep 30, 2018 -39.31%
Jun 30, 2018 -83.54%
Mar 31, 2018 -558.33%
Dec 31, 2017 -200.00%
Sep 30, 2017 -200.00%
Jun 30, 2017 104.40%
Mar 31, 2017 -4,450.00%
Dec 31, 2016 84.62%
Sep 30, 2016 -62.50%
Jun 30, 2016 60.00%
Mar 31, 2016 -900.00%
Dec 31, 2015 0.00%
Sep 30, 2015 0.00%
Jun 30, 2015 0.00%
Mar 31, 2015 -100.00%
Dec 31, 2014 0.00%
Sep 30, 2014 -171.91%
Jun 30, 2014 115.45%
Mar 31, 2014 -800.00%
Dec 31, 2013 50.00%
Sep 30, 2013 33.33%
Jun 30, 2013 -200.00%
Mar 31, 2013 -290.88%
Dec 31, 2012 91.47%
Sep 30, 2012 -200.00%
Jun 30, 2012 50.00%
Mar 31, 2012 -300.00%
Dec 31, 2011 150.00%
Sep 30, 2011 66.67%
Jun 30, 2011 -20.00%
Mar 31, 2011 -66.67%
Dec 31, 2010 -1,154.40%
Sep 30, 2010 105.69%